GlaxoSmithKline

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.

Lannett Company develops, manufactures, packages, markets and distributes pharmaceutical products sold under generic chemical names. The company uses its resources to research and develop projects that include new generic product offerings. Lannett's manufacturing facility consists of more than 31,000 square feet on nearly 3.5 acres owned by the company. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups and health maintenance organizations. Lannett Company is headquartered in Philadelphia.